Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · IEX Real-Time Price · USD
5.59
-0.45 (-7.45%)
At close: Jul 2, 2024, 4:00 PM
5.58
-0.01 (-0.18%)
After-hours: Jul 2, 2024, 7:26 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $177.12 million as of July 2, 2024. Its market cap has increased by 43.30% in one year.
Market Cap
177.12M
Enterprise Value
125.17M
1-Year Change
43.30%
Ranking
Category
Stock Price
$5.59
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $177.12M, a decrease of -63.71%. That is a compound annual growth rate of -28.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 197.20M | 5.23% |
| Dec 29, 2023 | 187.40M | 379.28% |
| Dec 30, 2022 | 39.10M | -81.46% |
| Dec 31, 2021 | 210.90M | -56.80% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genfit | 195.55M |
| Cybin | 195.39M |
| EDAP TMS | 194.79M |
| Butterfly Network | 193.77M |
| Aldeyra Therapeutics | 193.10M |
| Rani Therapeutics Holdings | 192.60M |
| Candel Therapeutics | 191.74M |
| MultiPlan | 189.85M |